Niche neuromodulation Target a rapidly growing medical device category: wireless, injectable, percutaneous neuromodulation devices that can be deployed in a lunchtime procedure and active the same day. Opportunities exist with surgical centers and outpatient clinics seeking minimally invasive solutions.

SMB scale Company is a small team (2-10 employees) with revenue under 1M, suggesting a need for scalable, lightweight sales and onboarding programs, white-labeling options, or partnerships that reduce implementation burden.

Clinical adoption Focus on early adopter clinics and specialists in neuromodulation, pain management, or peripheral nerve stimulation. Emphasize fast onboarding, percutaneous placement, and same-day therapy to shorten patient progress cycles.

Strategic partnerships Potential to pursue collaborations with larger medical device firms or distributors listed in the market (e.g., companies like Stryker, Medtronic, Boston Scientific) to scale reach, regulatory support, and channel access.

Digital maturity Leverage existing tech stack (AWS, Microsoft 365, WhatsApp Business) to enable remote sales outreach, streamlined customer support, and online education for clinicians, while enabling data-driven account targeting.